1. Home
  2. NPB vs ZVRA Comparison

NPB vs ZVRA Comparison

Compare NPB & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NPB
  • ZVRA
  • Stock Information
  • Founded
  • NPB 1999
  • ZVRA 2006
  • Country
  • NPB United States
  • ZVRA United States
  • Employees
  • NPB N/A
  • ZVRA N/A
  • Industry
  • NPB
  • ZVRA Biotechnology: Pharmaceutical Preparations
  • Sector
  • NPB
  • ZVRA Health Care
  • Exchange
  • NPB NYSE
  • ZVRA Nasdaq
  • Market Cap
  • NPB 421.7M
  • ZVRA 400.8M
  • IPO Year
  • NPB 2025
  • ZVRA 2015
  • Fundamental
  • Price
  • NPB $13.74
  • ZVRA $7.87
  • Analyst Decision
  • NPB Buy
  • ZVRA Strong Buy
  • Analyst Count
  • NPB 2
  • ZVRA 8
  • Target Price
  • NPB $17.25
  • ZVRA $22.29
  • AVG Volume (30 Days)
  • NPB 136.3K
  • ZVRA 440.4K
  • Earning Date
  • NPB 01-01-0001
  • ZVRA 05-13-2025
  • Dividend Yield
  • NPB 0.19%
  • ZVRA N/A
  • EPS Growth
  • NPB 108.67
  • ZVRA N/A
  • EPS
  • NPB 1.94
  • ZVRA N/A
  • Revenue
  • NPB $191,534,000.00
  • ZVRA $23,612,000.00
  • Revenue This Year
  • NPB $23.72
  • ZVRA $267.44
  • Revenue Next Year
  • NPB $14.51
  • ZVRA $90.10
  • P/E Ratio
  • NPB $7.00
  • ZVRA N/A
  • Revenue Growth
  • NPB N/A
  • ZVRA N/A
  • 52 Week Low
  • NPB $11.43
  • ZVRA $4.20
  • 52 Week High
  • NPB $14.98
  • ZVRA $9.76
  • Technical
  • Relative Strength Index (RSI)
  • NPB N/A
  • ZVRA 58.11
  • Support Level
  • NPB N/A
  • ZVRA $7.26
  • Resistance Level
  • NPB N/A
  • ZVRA $8.10
  • Average True Range (ATR)
  • NPB 0.00
  • ZVRA 0.36
  • MACD
  • NPB 0.00
  • ZVRA 0.08
  • Stochastic Oscillator
  • NPB 0.00
  • ZVRA 80.34

About NPB NORTHPOINTE BANCSHARES INC

Northpointe Bancshares Inc operates its business through its wholly-owned banking subsidiary, Its lending focus is the origination of residential mortgages throughout the United States. The majority of these loans are sold in the secondary market through a network of investors. The Company has also developed mortgage advance program that provides funding to pre-approved mortgage bankers who originate and sell individual conforming and non-qualified loan products in the secondary market. The Company continues to service loans that were originated and sold to investors as well as loans held in its portfolio which were originated and selectively held in portfolio.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.

Share on Social Networks: